DexCom Inc (NASDAQ:DXCM)
During the Trading Day
| 39.05 |  +0.62 / +1.61% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 39.05 |  0.00 / 0.00% |
Volume: 11.0K |
Latest DXCM News | Press Releases
| 5 New Medical Technologies For Diabetics Jul 18 / Benzinga |
Today’s Trading
| Previous close | 38.43 |
| Today’s open | 38.03 |
| Day’s range | 37.86 - 39.29 |
| Volume | 763,111 |
| Average volume (3 months) | 821,479 |
| Market cap | $2.9B |
| Dividend yield | -- |
Data as of 4:00pm ET, 07/25/2014
Growth & Valuation
| Earnings growth (last year) | +46.84% |
| Earnings growth (this year) | +23.44% |
| Earnings growth (next 5 years) | +32.50% |
| Revenue growth (last year) | +60.16% |
| P/E ratio | NM |
| Price/Sales | 15.74 |
| Price/Book | 33.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | -0.11 | -0.27% |
| MRMindray Medical Inte... | +0.60 | +2.01% |
| GMEDGlobus Medical Inc | -0.22 | -0.95% |
| PODDInsulet Corp | -0.91 | -2.45% |
Data as of 4:05pm ET, 07/25/2014
Financials
| Next reporting date | August 4, 2014 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $160.0M |
| Annual profit (last year) | -$29.8M |
| Net profit margin | -18.63% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Terry H. Gregg |
President, Chief Operating Officer & Director Kevin Ronald Sayer |
Corporate headquarters San Diego, California |
Forecasts
.
